|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,640 GBX | +0.28% |
|
+3.60% | +13.12% |
| 07:58pm | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
| 07:00pm | GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines | MT |
Jan 26 (Reuters) -
* GALVANI BIOELECTRONICS ANNOUNCES WORLD'S FIRST INVESTIGATIONAL TREATMENT OF RHEUMATOID ARTHRITIS USING SPLENIC NERVE STIMULATION
* GALVANI BIOELECTRONICS - CO HAS ALSO INITIATED A LARGER US-BASED RANDOMISED, DOUBLE-BLINDED FEASIBILITY STUDY, APPROVED BY U.S. FDA Source text for Eikon: Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +13.12% | 83.1B | |
| +24.17% | 562B | |
| -6.16% | 358B | |
| +19.68% | 322B | |
| +7.60% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -11.83% | 149B | |
| -6.24% | 146B |
GSK PLC 
